Kiminari Ito

Title: Kiminari Ito: Innovator in Cord Blood-Derived Therapies

Introduction

Kiminari Ito is a notable inventor based in Hokkaido, Japan. He has made significant contributions to the field of medical innovations, particularly in therapies derived from cord blood. With a total of 2 patents, his work focuses on the prevention and treatment of various diseases using activated lymphocytes.

Latest Patents

Kiminari Ito's latest patents include "Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations." This invention highlights the effectiveness of activated lymphocytes derived from cord blood in preventing and treating tumors and infections. The preparation involves segregating lymphocytes from cord blood and proliferating them in vitro, which can also aid in preventing disease recurrence and promoting stem cell take. Another significant patent is "Compositions comprising, as the main ingredient, allogenic activated-CD4+ cells and method for producing and using the same." This invention focuses on the beneficial effects of allogenic activated-CD4+ cells in preventing tumor recidivism and treating various infections without causing serious graft-versus-host disease (GVHD).

Career Highlights

Throughout his career, Kiminari Ito has worked with various organizations, including Humantec Ltd. His innovative approaches have positioned him as a key figure in the development of advanced medical therapies.

Collaborations

Kiminari Ito has collaborated with notable individuals in his field, including Teruaki Sekine and Kenzo Bamba. Their combined expertise has contributed to the advancement of his research and inventions.

Conclusion

Kiminari Ito's work in the field of cord blood-derived therapies showcases his dedication to medical innovation. His patents reflect a commitment to improving treatment options for patients facing serious health challenges.